Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)

Basit Öğe Kaydı
dc.authoridVenerito, Marino/0000-0001-8581-0974
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authoridRimassa, Lorenza/0000-0001-9957-3615
dc.authorwosidVenerito, Marino/AAF-4493-2020
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.authorwosidRimassa, Lorenza/N-4884-2016
dc.contributor.authorVenerito, M.
dc.contributor.authorRimassa, L.
dc.contributor.authorCicin, I
dc.contributor.authorBlanc, J-F
dc.contributor.authorKluempen, H-J
dc.contributor.authorZagonel, V
dc.contributor.authorTran, A.
dc.date.accessioned2024-06-12T11:24:06Z
dc.date.available2024-06-12T11:24:06Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage283en_US
dc.identifier.issn2296-5270
dc.identifier.issn2296-5262
dc.identifier.startpage283en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26808
dc.identifier.volume41en_US
dc.identifier.wosWOS:000446816500688en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofOncology Research And Treatmenten_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleOutcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu